Stock TORNTPHARM TORRENT PHARMACEUTICALS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Torrent Pharmaceuticals Limited NSE India S.E.

Equities

TORNTPHARM

INE685A01028

Delayed NSE India S.E.
Other stock markets
 09:18:28 04/07/2024 BST 		5-day change 1st Jan Change
2,853 INR +0.55% Intraday chart for Torrent Pharmaceuticals Limited +2.90% +23.71%
06-21 Takeda gives Sun Pharma, Cipla rights to commercialize gastro drug in India RE
06-06 Torrent Pharma Signs Deal with Japan's Takeda to Market Acid-Related Disorders Drug in India MT

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Takeda gives Sun Pharma, Cipla rights to commercialize gastro drug in India
Torrent Pharma Signs Deal with Japan's Takeda to Market Acid-Related Disorders Drug in India
Torrent Pharmaceuticals Enters into Non-Exclusive Patent Licensing Agreement with Takeda Pharmaceuticals to Commercialize Its Novel Gastrointestinal Drug in India
INDIA STOCKS-Indian shares at record highs, boosted by pharma stocks, Adani Ports
Torrent Pharmaceuticals' Consolidated Profit Jumps in Fiscal Q4; EPS Tops Estimates
Torrent Pharma Board Approves to Raise INR 50,000 Million
Torrent Pharmaceuticals Limited Announces Stepping Down of Jinesh Shah as the Director, Effective from 23 July 2024
Torrent Pharmaceuticals Limited Recommends Final Dividend for the Financial Year Ended 31 March, 2024, Payable on or Around 31 July, 2024
Torrent Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2024
Torrent Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024
Promoter group to sell stake worth $316 million in India's Cipla, CNBC-TV18 reports
Torrent Pharmaceuticals Limited Announces Change in Directorate , Effective 31 March 2024
Torrent Pharmaceuticals Limited Announces Superannuation of Ashok Modi as Executive Director
Torrent Pharmaceuticals Posts Gains in Fiscal Q3 Consolidated Net Profit
Torrent Pharmaceuticals' Consolidated Profit in Fiscal Q3
India's Torrent Pharma posts higher Q3 profit on strong domestic demand
Torrent Pharmaceuticals Limited Announces Interim Dividend, Payable on or around 23 February, 2024
Torrent Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
India's Glenmark Life Sciences posts Q3 profit rise; strong orderbook ahead, says CEO
Torrent Pharmaceuticals Forms New Wholly-Owned Arm in Colombia
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. TORNTPHARM Stock
  4. TORNTPHARM Stock
  5. News Torrent Pharmaceuticals Limited
  6. Other languages